We are live on ! Find out more
HSTO

Histogen Inc. Common Stock
HSTO

Delisted

HSTO was delisted on the 4th of October, 2023.

Back to rankings

13 hedge funds and large institutions have $90.4K invested in Histogen Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 13 → 13 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

48% less capital invested

Capital invested by funds: $174K → $90.4K (-$83.6K)

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$14.7K
2
Renaissance Technologies
Renaissance Technologies
New York
+$11.8K
3
TRCT
Tower Research Capital (TRC)
New York
+$7.24K
4
Wells Fargo
Wells Fargo
California
+$50
5
BFEC
Benjamin F. Edwards & Company
Missouri
+$6

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$37K
2
Prudential Financial
Prudential Financial
New Jersey
-$26K
3
Morgan Stanley
Morgan Stanley
New York
-$3K
4
TSS
Two Sigma Securities
New York
-$914
5
UBS Group
UBS Group
Switzerland
-$884

HSTO Hedge Fund Activity: Q4 2022 in Review

13 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2022, worth a combined $90.4K — down 48% from $174K a quarter earlier.

Fund positioning in HSTO was balanced in Q4 2022: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 4 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $14.7K. The largest seller was Virtu Financial, exiting entirely with an estimated $37K sold.

  • 13 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $90.4K of Histogen Inc. Common Stock stock for Q4 2022, down 48% quarter-over-quarter.
  • 3 funds opened new Histogen Inc. Common Stock positions in Q4 2022 and 3 closed out, a net change of 0 holders.
  • The largest Histogen Inc. Common Stock buyer in Q4 2022 was Jane Street, an estimated $14.7K added.
  • The largest Histogen Inc. Common Stock seller in Q4 2022 was Virtu Financial, an estimated $37K sold.

Based on aggregated 13F filings for Q4 2022.